British Society of Blood and Marrow Transplantation and Cellular Therapy
an organisation for those with a professional interest in haematopoietic cell transplantation and cellular therapies
October 2024, Issue 10
Dear BSBMTCT member,
Hope everyone is doing well and getting ready for darker days and colder nights.
It was lovely to see so many of you at the annual Anthony Nolan Clinical Retreat held in Birmingham on the 17th and 18th October. It was an extra special year celebrating 50 years of Anthony Nolan. We had had a whistle stop tour of the key events from where it began in 1974 when Shirley Nolan started the world’s first stem cell register to save her son’s life by trying to find him a donor, to present day where there has been huge progress and advancements in clinical practice and technologies. However, there is still work to be done and these events give us an opportunity to discuss ideas and talk about how we might try to achieve this. Henny Braund, CEO of Anthony Nolan chaired a hackathon where 4 groups competed on different missions based on “How the new government can make a real difference in cell therapy”. Delighted to share that Group 1 won, photo below. What an amazing event full of great ideas, ambition and determination to save and improve the lives of many. Thank you to all those at Anthony Nolan for hosting an excellent event.
We would like to thank everyone that was involved in the strategic review consultation process. We very much appreciate and value your time and feedback. We have taken it all onboard and have started to draft a 5-year strategic plan which we hope we can share with you all shortly.
The election and nomination process for the New BSBMTCT President Elect and First Chair of BSBMTCT Complications Sub Committee began on the 12th September and nominations closed on Friday 11th October. The voting process began on the 21st October 2024 and will be open until 12 midnight on the 4th November 2024. Results will be announced via email and via the monthly BSBMTCT Bulletin. Each centre programme director gets one vote each.
The BSBMTCT public report consultation was extended until Friday 18th October to try and get more response from centres. We will be sharing our findings and next steps in due course.
As many of you know, our 2024 Annual BSBMTCT Executive Summary of Transplant and Cellular Therapy Outcomes in UK_ROI_ A Report for Commissioners_15th_Edn and the individual centre reports has been delayed. We are hoping to be able to share more helpful dates of when these might be available.
We hope to see a lot of you at our BSBMTCT Education Day in November, details below!
We would like to remind you of the upcoming events:
- BSBMTCT Education Day – Thursday 7th November 2024 – Hybrid – Agenda and registration details: https://bsbmtct.org/events/bsbmtct-education-day-7th-november-2024/
- BSBMTCT DM Training Day – Thursday 14th November 2024 – Virtual – Registration link https://bsbmtct.org/data-managers/7th-data-management-training-day-registration/
- BSBMTCT CTSC Meeting – Monday 18th November 2024 – Virtual
Our Very Best Wishes, Eduardo Olavarria, John Snowden, Deborah Richardson, Fiona Dignan, Harpreet Kaur & Julia Lee
British Society of Blood and Marrow Transplantation and Cellular Therapies
Guy's Hospital, Great Maze Pond London.
SE1 9RT United Kingdom
The BSBMTCT is not responsible for the content of external sites
